Purpose
Fuchs dystrophy is the leading indication for corneal transplantation in the United States. A CTG18.1 trinucleotide repeat in TCF4 correlates with increased severity in Fuchs dystrophy; however, quantitative estimates of increased transplantation risk, including effects of age and gender, are unclear.
Methods
In a tertiary institution clinical practice, 574 participants were enrolled in a longitudinal study of Fuchs dystrophy after slit-lamp biomicroscopy confirmed significant central guttae and/or corneal transplantation in both eyes. We documented clinical history, examination findings, and demographic information. We acquired blood samples, extracted DNA and sequenced the CTG18.1 trinucleotide repeat in TCF4. In this retrospective case-control study, the number of participants with triplet expansion, defined as greater than 40 CTG repeats, and transplantation status were assessed. Kaplan-Meier estimates of timing and transplantation events were produced. Cox proportional hazard regression model was utilized to assess for the relationship between age, gender, triplet expansion, and surgery.
Results
A total of 106 participants (18.5%) previously underwent corneal transplantation in at least one eye at the time of initial evaluation. A higher proportion of individuals harboring allele expansion had undergone transplantation (78/357, 21.8%) compared to those without the expanded allele (28/217, 12.9%), a significant association (p=0.007). Log-rank test demonstrates a significant difference in survival function over time (p=0.027), with hazard ratio of 1.64 (95% CI, 1.05 to 2.55).
Conclusions
Expansion of the TCF4 CTG trinucleotide repeat was associated with 1.64 times higher likelihood of corneal transplantation at a given age in patients with Fuchs dystrophy.